Robert C. Schroeder's Insider Trades & SAST Disclosures

Robert C. Schroeder's most recent trade in TNF Pharmaceuticals Inc. was a trade of 43,930 Common Stock done . Disclosure was reported to the exchange on April 16, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TNF Pharmaceuticals Inc.
Robert C. Schroeder Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2021 43,930 43,930 - - Common Stock
TNF Pharmaceuticals Inc.
Robert C. Schroeder Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2021 43,930 0 - - Restricted Stock Units
TNF Pharmaceuticals Inc.
Robert C. Schroeder Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.94 per share. 16 Apr 2021 14,694 29,236 - 4.9 72,588 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades